DysphagiaNCT04855838
Dysphagia After Anterior Cervical Spine Surgery
A study testing Oral neuromuscular training in people with Dysphagia and Cervical Spinal Cord Injury, run by Umeå University at 1 site in Sweden.
Trial summary
The purpose of this research project is to investigate the incidence of impaired swallowing (dysphagia) after anterior cervical spine surgery (ACSS) and to study the long-term effect of dysphagia on nutritional status 12 ± 3 months later. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dysphagia, Cervical Spinal Cord Injury
- What is being tested?
- Oral neuromuscular training
- Type of treatment
- Pill or oral medicine, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteSweden
- Study dates
- 17 Dec 2020to 31 Dec 2024
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients enrolled at the University Hospital of Umeå who have undergone ACSS between C2 and Th1 level due to trauma are eligible participants in the first part of the study.
- Eligibility criteria to participate in part 2 is swallowing dysfunction on FEES at 4±1-week post-operation
Who cannot join
- Patients <18 years of age
- known dysphagia prior to the trauma/injury
- affected brainstem that is shown on a CT or MRI
- severe brain damage.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
University Hospital of Umeå
Umeå
Patricia Hägglund, PhD/SLP, patricia.hagglund@umu.se
About this study
Official title: Impaired Swallowing Function After Anterior Cervical Spine Surgery- Incidence, Long-term Effect on Nutrition and Effect of Oral Neuromuscular Training
The purpose of this research project is to investigate the incidence of impaired swallowing (dysphagia) after anterior cervical spine surgery (ACSS) and to study the long-term effect of dysphagia on nutritional status 12 ± 3 months later. Furthermore, to investigate the effect of a new rehabilitation method for dysphagia among individuals with swallowing dysfunction after ACSS.
Read the detailed description
Study design: This study contains of two parts. The first part of this study is a prospective observational cohort study with consecutive observations on the characterization of incidence of and factors related to dysphagia after ACSS (within 14 days of surgery and 2-3 weeks later), and investigation the long-term effect of dysphagia on nutritional status 12 ± 3 months later.
The second part of this study is a prospective randomized open-label trial with blinded evaluators (PROBE-design) that compare conventional care to neuromuscular training in the treatment of dysphagia.
Subjects and procedure: Part 1: All patients enrolled at the University Hospital of Umeå who have undergone ACSS between C2 and Th1 level due to trauma are eligible participants in the first part of the study (the observational cohort study). All participants will have their swallowing function assessed with a flexible video endoscopic evaluation of swallowing (i.e. FESS) within 14 days after surgery and have their nutritional status examined with the clinical test Nutrition Risk Screening-2002 (NRS-2002) and blood sample for biomarkers of malnutrition (i.e., levels of Albumin, levels of Leptin, Ghrelin and Adiponektin and also metabolites as ketone bodies (3 hydoxibutyrat and acetoacetate). The swallowing assessment and nutritional screening with NRS-2002 will be performed by a speech- language pathologist or physician in otolaryngology. Blood sample will be collected by a nurse at the unit where the participant is staying, who have extended knowledge in the procedure. If a swallowing dysfunction is present the patient will be followed-up within 2-3 weeks later (i.e., 4±1- week post-operation) to assess the spontaneous recovery. During the period from the first assessment to the follow-up all patients will be given conventional care (e.g., postural adjustments, swallowing maneuvers, modified consistency of solid and/or liquid food). If the patient has a remaining swallowing dysfunction at the reassessment 4±1-week post-operation the patient will be asked to participate in part 2 of the study (the interventional study). All patients participating in part 1, will have another examination of nutritional status at 12 ± 3 months after ACSS. In order to study the long-term effect of dysphagia on nutrition.
Part 2: Participants with presenting swallowing dysfunction at the reassessment 4±1 week post- operation will after given their oral or written consent be randomly assigned to 8 weeks of either conventional care (control group) or oral neuromuscular training with an oral device (intervention group). Randomization will be performed web-based using the program MINIM with minimization/ stratification for aspiration (yes/no) on FEES leading to an equal balance of prognostic important variable at baseline. In each group, swallowing function, swallowing-related quality of life measured by the Swallowing Quality of life Questionnaire (SWAL-QOL) and an examination of nutritional status with the clinical screening NRS-2002 and blood samples will be assessed at baseline (i.e. 4±1 week post-surgery assessment), eight weeks after baseline (end-of treatment), and 12 ± 3 months post-treatment. A swallowing assessment will also be performed four weeks into the treatment period. If oral neuromuscular training with an oral device is found to be effective in the intervention group, it will be also offered to the control group after the study is finished. All assessments will be carried out at the University Hospital of Umeå. All the assessments of the participants' swallowing function will be recorded, and the evaluators will be blinded to treatment at the assessment of the FEES.
Clinical data will be obtained from the participants' journal part 1 and 2 regarding sex, age, weight, height, body mass index (BMI), presence of a tracheostomy and if presence what type of tube used, length of intubation, presence of pneumonia, length stay at the hospital or ICU, medical diagnoses, the severity of the spinal cord injury according to the American Spinal Injury Association (ASIA) impairment scale, level of spinal cord injury and whether left or right approach was used during the ACSS will be recorded. Prior to the first assessment of the participant's swallowing function, written or oral (if tetraplegia) consent will be collected from each patient.
- Conditions
- Dysphagia, Cervical Spinal Cord Injury
- Being tested
- Oral neuromuscular training
- Keywords
- Swallowing disorder, Anterior cervical spine surgery, Intervention, Incidens, Nutritional status
- Medical subject headings
- Deglutition Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Oral neuromuscular trainingDevice
The oral device is used for 30 seconds, three times a day, before meals and implies new possibilities for training of the orofacial and pharyngeal muscles.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Intensive training with oral neuromuscular device (intervention group) and traditional compensatory swallowing training under 8 weeks with start 4 (±1) weeks post-operation. Receives: Device: Oral neuromuscular training |
| Control group | No intervention | Traditional compensatory swallowing training under 8 weeks with start 4 (±1) weeks post-operation. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dysphagia severity
Change in swallowing function measured by FEES.
Measured: At start, at 4 weeks into the training, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Secondary outcomes (5)
Swallowing ability
Change in swallowing ability measured by the FOIS (functional oral intake scale)
Measured: At start, at 4 weeks into the training, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Swallowing related quality of life
Change in quality of life related to swallowing measured by the SWAL-QOL questionnaire.
Measured: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Nutritional status
Changes in nutritional status measured by the NRS-2002
Measured: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Nutritional and metabolic status
Changes in nutritional status measured by blood samples (i.e., levels of Albumin, levels of Leptin, Ghrelin and Adiponektin and also metabolites as ketone bodies)
Measured: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
The frequency of pneumonia
The frequency of pneumonia will be will be registered and compared between the intervention and control group.
Measured: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2021
- Study start17 Dec 2020
- Primary completion31 Dec 2024 (estimated)
- Study completion31 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DysphagiaStudies of the same condition, open and under way.
- More trials run by Umeå UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Umeå University
- Sponsor type
- University, hospital or other
- Collaborators
- University Hospital, Umeå
- Responsible party
- Sponsor
- Investigators
- Patricia Hägglund, PhD/SLP, Principal investigator, Umeå University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04855838
- Sponsor's protocol ID
- 2019-06543
- Other IDs
- 2019
- Status last verified
- Dec 2024
- First submitted
- 20 Apr 2021
- Last updated
- 11 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impaired Swallowing Function After Anterior Cervical Spine Surgery- Incidence, Long-term Effect on Nutrition and Effect of Oral Neuromuscular Training
- ClinicalTrials.gov ID
- NCT04855838
- Acronym / sponsor ID
- 2019-06543
- Conditions
- Dysphagia, Cervical Spinal Cord Injury
- Keywords
- Swallowing disorder, Anterior cervical spine surgery, Intervention, Incidens, Nutritional status
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Umeå UniversityUniversity, hospital or other
- Collaborators
- University Hospital, Umeå
- Study start
- 17 Dec 2020 (actual)
- Primary completion
- 31 Dec 2024 (estimated)
- Study completion
- 31 Dec 2024 (estimated)
- First posted
- 22 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research project is to investigate the incidence of impaired swallowing (dysphagia) after anterior cervical spine surgery (ACSS) and to study the long-term effect of dysphagia on nutritional status 12 ± 3 months later. Furthermore, to investigate the effect of a new rehabilitation method for dysphagia among individuals with swallowing dysfunction after ACSS.
Detailed description
Study design: This study contains of two parts. The first part of this study is a prospective observational cohort study with consecutive observations on the characterization of incidence of and factors related to dysphagia after ACSS (within 14 days of surgery and 2-3 weeks later), and investigation the long-term effect of dysphagia on nutritional status 12 ± 3 months later.
The second part of this study is a prospective randomized open-label trial with blinded evaluators (PROBE-design) that compare conventional care to neuromuscular training in the treatment of dysphagia.
Subjects and procedure: Part 1: All patients enrolled at the University Hospital of Umeå who have undergone ACSS between C2 and Th1 level due to trauma are eligible participants in the first part of the study (the observational cohort study). All participants will have their swallowing function assessed with a flexible video endoscopic evaluation of swallowing (i.e. FESS) within 14 days after surgery and have their nutritional status examined with the clinical test Nutrition Risk Screening-2002 (NRS-2002) and blood sample for biomarkers of malnutrition (i.e., levels of Albumin, levels of Leptin, Ghrelin and Adiponektin and also metabolites as ketone bodies (3 hydoxibutyrat and acetoacetate). The swallowing assessment and nutritional screening with NRS-2002 will be performed by a speech- language pathologist or physician in otolaryngology. Blood sample will be collected by a nurse at the unit where the participant is staying, who have extended knowledge in the procedure. If a swallowing dysfunction is present the patient will be followed-up within 2-3 weeks later (i.e., 4±1- week post-operation) to assess the spontaneous recovery. During the period from the first assessment to the follow-up all patients will be given conventional care (e.g., postural adjustments, swallowing maneuvers, modified consistency of solid and/or liquid food). If the patient has a remaining swallowing dysfunction at the reassessment 4±1-week post-operation the patient will be asked to participate in part 2 of the study (the interventional study). All patients participating in part 1, will have another examination of nutritional status at 12 ± 3 months after ACSS. In order to study the long-term effect of dysphagia on nutrition.
Part 2: Participants with presenting swallowing dysfunction at the reassessment 4±1 week post- operation will after given their oral or written consent be randomly assigned to 8 weeks of either conventional care (control group) or oral neuromuscular training with an oral device (intervention group). Randomization will be performed web-based using the program MINIM with minimization/ stratification for aspiration (yes/no) on FEES leading to an equal balance of prognostic important variable at baseline. In each group, swallowing function, swallowing-related quality of life measured by the Swallowing Quality of life Questionnaire (SWAL-QOL) and an examination of nutritional status with the clinical screening NRS-2002 and blood samples will be assessed at baseline (i.e. 4±1 week post-surgery assessment), eight weeks after baseline (end-of treatment), and 12 ± 3 months post-treatment. A swallowing assessment will also be performed four weeks into the treatment period. If oral neuromuscular training with an oral device is found to be effective in the intervention group, it will be also offered to the control group after the study is finished. All assessments will be carried out at the University Hospital of Umeå. All the assessments of the participants' swallowing function will be recorded, and the evaluators will be blinded to treatment at the assessment of the FEES.
Clinical data will be obtained from the participants' journal part 1 and 2 regarding sex, age, weight, height, body mass index (BMI), presence of a tracheostomy and if presence what type of tube used, length of intubation, presence of pneumonia, length stay at the hospital or ICU, medical diagnoses, the severity of the spinal cord injury according to the American Spinal Injury Association (ASIA) impairment scale, level of spinal cord injury and whether left or right approach was used during the ACSS will be recorded. Prior to the first assessment of the participant's swallowing function, written or oral (if tetraplegia) consent will be collected from each patient.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Device: Oral neuromuscular trainingIntensive training with oral neuromuscular device (intervention group) and traditional compensatory swallowing training under 8 weeks with start 4 (±1) weeks post-operation. |
| Control group | No intervention | –Traditional compensatory swallowing training under 8 weeks with start 4 (±1) weeks post-operation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All patients enrolled at the University Hospital of Umeå who have undergone ACSS between C2 and Th1 level due to trauma are eligible participants in the first part of the study.
- Eligibility criteria to participate in part 2 is swallowing dysfunction on FEES at 4±1-week post-operation
Key exclusion criteria (4 listed)
- Patients <18 years of age
- known dysphagia prior to the trauma/injury
- affected brainstem that is shown on a CT or MRI
- severe brain damage.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Oral neuromuscular trainingThe oral device is used for 30 seconds, three times a day, before meals and implies new possibilities for training of the orofacial and pharyngeal muscles. | Device | Intervention group |
Primary outcome
Dysphagia severity
Time frame: At start, at 4 weeks into the training, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Change in swallowing function measured by FEES.
5 secondary outcomes
Swallowing ability
Time frame: At start, at 4 weeks into the training, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Swallowing related quality of life
Time frame: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Nutritional status
Time frame: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Nutritional and metabolic status
Time frame: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
The frequency of pneumonia
Time frame: At start, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2024.
- Individual participant dataSharing planned: No
Related trials for Dysphagia
Recruiting
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
Dysphagia, Eosinophilic Esophagitis
Recruiting
taVNS in Infants Severe Dysphagia
Dysphagia, Swallowing Disorders
Not yet recruiting
Standardizing Swallow Pressure Measurements
Dysphagia
Active, not recruitingObservational study
Dexmedetomidine Nasal Spray and Postoperative Sore Throat After Bronchoscopy
Postoperative Sore Throat, Bronchoscopy
Not yet recruiting
EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia
Ischemic Stroke, Post-stroke Dysphagia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Patricia Hägglund, PhD/SLP principal investigator
Umeå University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Oral neuromuscular training in people with Dysphagia and Cervical Spinal Cord Injury, run by Umeå University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 11 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Patricia Hägglund, PhD/SLP (+46907850000, patricia.hagglund@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dysphagia severity (time frame: At start, at 4 weeks into the training, at end of treatment (after 8 weeks) and 12 ± 3 months post-intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2024; AzTrials last refreshed its copy on 6 Nov 2026.